Literature DB >> 16358591

[The role of copper and magnesium in the pathogenesis and treatment of affective disorders].

Marcin Siwek1, Andrzej Wróbel, Dominika Dudek, Gabriel Nowak, Andrzej Zieba.   

Abstract

Magnesium and copper are important modulators of NMDA-receptor activity. Recent data indicate that disturbances of glutamatergic transmission (especially via NMDA-receptor) are involved in pathogenesis of mood disorders. Magnesium deficiency, the same as disturbances in turn over of copper, are related to a variety of psychological symptoms especially depression. There are many reports indicating significant changes in blood levels of magnesium or copper during a depressive episode. Moreover magnesium exhibits antidepressant-like and anxiolytic-like effects in animal models of depression, in rodents. This article reviews the alterations in central and peripheral magnesium and copper homeostasis in relation to pathophysiology and treatment of depression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16358591

Source DB:  PubMed          Journal:  Psychiatr Pol        ISSN: 0033-2674            Impact factor:   1.657


  3 in total

Review 1.  Complementary and alternative medicine therapies to promote healthy moods.

Authors:  Kathi J Kemper; Scott Shannon
Journal:  Pediatr Clin North Am       Date:  2007-12       Impact factor: 3.278

Review 2.  Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis.

Authors:  James J DiNicolantonio; James H O'Keefe; William Wilson
Journal:  Open Heart       Date:  2018-01-13

3.  Copper and Zinc as Potential Biomarkers of Mood Disorders and Pandemic Syndrome.

Authors:  Magdalena Świądro; Klaudia Ordon; Małgorzata Herman; Dominika Dudek; Renata Wietecha-Posłuszny
Journal:  Molecules       Date:  2021-12-24       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.